financetom
Business
financetom
/
Business
/
LogicMark Prices $14.4 Million Public Offering, Plans Special Stockholder Meeting to Vote on Reverse Stock Split
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LogicMark Prices $14.4 Million Public Offering, Plans Special Stockholder Meeting to Vote on Reverse Stock Split
Feb 18, 2025 7:34 AM

10:16 AM EST, 02/18/2025 (MT Newswires) -- LogicMark ( LGMK ) said Tuesday it priced a public offering of about 2.3 million units and 22.1 million pre-funded units at $0.59 apiece for gross proceeds of $14.4 million.

Each unit consisted of one share or one pre-funded warrant, one series C warrant and one series D warrant. The series C and D warrants will be exercisable only with stockholder approval and, if necessary, a charter amendment for a reverse stock split or share increase, LogicMark ( LGMK ) said.

The company said it intends to use the net proceeds from the offering, slated to close Tuesday, for sales, marketing, working capital, and general corporate purposes.

LogicMark ( LGMK ) said it will hold a special stockholder meeting on March 24 to vote on a reverse stock split, the issuance of 20% or more of its common shares in connection with its public offering, and an increase in authorized shares. Stockholders of record as of Tuesday are eligible to vote, the company added.

Shares of LogicMark ( LGMK ) were down more than 46% in recent Tuesday trading.

Price: 0.32, Change: -0.27, Percent Change: -46.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: EU to Delay Vote to Ratify Trade Deal With US
Market Chatter: EU to Delay Vote to Ratify Trade Deal With US
Mar 11, 2026
09:41 AM EST, 01/21/2026 (MT Newswires) -- The European Parliament will delay a vote on ratifying the bloc's trade deal with the US, Bloomberg reported Wednesday, citing people familiar with the matter. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is...
Zura Bio Appoints Sandeep Kulkarni as CEO
Zura Bio Appoints Sandeep Kulkarni as CEO
Mar 11, 2026
09:36 AM EST, 01/21/2026 (MT Newswires) -- Zura Bio ( ZURA ) said Wednesday it has appointed Sandeep Kulkarni as chief executive officer, effective immediately. Kulkarni succeeds Kim Davis, who has served as the company's interim CEO since October, after Robert Lisicki went on medical leave, the company said. Davis will continue in her roles as chief operating officer, chief...
Smithfield Foods to Buy Nathan's Famous in $450 Million Cash Transaction
Smithfield Foods to Buy Nathan's Famous in $450 Million Cash Transaction
Mar 11, 2026
08:00 AM EST, 01/21/2026 (MT Newswires) -- Smithfield Foods ( SFD ) has agreed to acquire all outstanding shares of Nathan's Famous (NATH) for $102 per share in cash, representing an enterprise value of about $450 million, the companies said Wednesday. The transaction will be funded with cash on hand and is expected to be immediately accretive to Smithfield's adjusted...
Dr Reddy's gets regulatory nod to sell generic Ozempic in India, targets 12 million pens in first year
Dr Reddy's gets regulatory nod to sell generic Ozempic in India, targets 12 million pens in first year
Mar 11, 2026
By Rishika Sadam and Kashish Tandon HYDERABAD, Jan 21 (Reuters) - Indian drugmaker Dr Reddy's, which reported a smaller-than-expected fall in quarterly profit on Wednesday, said that it has received an approval from the country's drug regulator to manufacture and sell the generic ‌version of blockbuster diabetes drug Ozempic. The company plans to sell 12 million injectable Semaglutide pens in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved